title: Changes in dopamine release and dopamine D2/3 receptor levels with the development of mild obesity.
authors.affiliation: Department of Radiology, Vanderbilt University School of Medicine, Nashville, Tennessee, 37232.
authors.forename: Robert M
authors.initials: RM
authors.lastname: Kessler
authors.forename: David H
authors.initials: DH
authors.lastname: Zald
authors.forename: Mohammad Sib
authors.initials: MS
authors.lastname: Ansari
authors.forename: Rui
authors.initials: R
authors.lastname: Li
authors.forename: Ronald L
authors.initials: RL
authors.lastname: Cowan
mesh_terms: D000328:Adult; D001549:Benzamides / Q000493:pharmacokinetics; D001921:Brain / Q000000981:diagnostic imaging* / Q000378:metabolism; D016022:Case-Control Studies; D004298:Dopamine / Q000378:metabolism*; D005260:Female; D005462:Fluorine Radioisotopes / Q000493:pharmacokinetics; D006801:Humans; D008297:Male; D009765:Obesity / Q000000981:diagnostic imaging* / Q000378:metabolism; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D017448:Receptors, Dopamine D2 / Q000378:metabolism*; D050637:Receptors, Dopamine D3 / Q000378:metabolism*
chemical_list: D001549:Benzamides; D005462:Fluorine Radioisotopes; D019275:Radiopharmaceuticals; D017448:Receptors, Dopamine D2; D050637:Receptors, Dopamine D3; C574003:fallypride; D004298:Dopamine
keywords: dopamine; dopamine D2/3 receptors; dopamine release; mild obesity; obesity